+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Research Equipment Grant

Cancer Institute NSW

The Cancer Institute NSW Research Equipment Grant (REG) ensures that the state has world class infrastructure to accelerate cancer research and realise clinical benefits.

This scheme will support research infrastructure where there is a clearly demonstrated need and where the equipment will substantially improve research productivity. Funding is available for research platforms, core equipment and capacities to enhance the cancer research effort in NSW.

Objectives

The Research Equipment Grant aims to support capability development and greater levels of collaboration across the cancer research sector.

Funding available

Between $300,000 and $600,000 (excl. GST) per application for a single piece of equipment. Equipment must be purchased within 12 months of the commencement of the grant. Co-contributions may be provided by the Administering Institution and/or other funders where the proposed equipment exceeds $600,000.

Applications

Applications must be submitted via email to CINSW-Grants@health.nsw.gov.au by 12 pm, Tuesday 28 April 2026.

Reporting requirements

In accordance with the Cancer Institute NSW Competitive Grants Agreement, successful applicants must submit Progress and Final Reports, inclusive of financial reporting, according to the schedule outlined in their agreement.

AI Based Application Success Predictor

🌏 1. Alignment with NSW Cancer Plan (Top Predictor)

All funded projects must align with:
- NSW Cancer Plan priorities
- Goals to reduce cancer burden in New South Wales

👉 Misalignment with state priorities is a major rejection reason

🎯 2. Clear Impact on Patients or Population

Successful proposals clearly demonstrate:

Improvements in:
- Cancer outcomes
- Early detection
- Treatment or care delivery
Real-world applicability in NSW

👉 Emphasis is on health system and population impact, not just publications

🔄 3. Strong Translational Focus (Critical Predictor)

Movement from:
- Research → clinical practice → policy
Projects that:
- Improve implementation of care
- Translate evidence into practice

👉 Translational and implementation research are highly prioritized

🤝 4. Collaboration & Health System Integration

High success rates are seen in:

Partnerships between:
- Universities
- Hospitals
- Local Health Districts
Integration with real clinical workflows

👉 Collaboration is essential for statewide impact

🧑‍🤝‍🧑 5. Focus on Priority & Underserved Populations

CINSW strongly values projects targeting:

Aboriginal communities
Rural and remote populations
Multicultural groups

👉 Equity-focused proposals have higher success probability

🧪 6. Feasible & Well-Structured Study Design

Realistic implementation plan
Clear milestones and deliverables
Risk management strategy

👉 Lack of feasibility or risk planning is a common rejection factor

👩‍🔬 7. Investigator Track Record & Delivery Capacity

Evidence of:
- Publications
- Previous relevant work
Demonstrated ability to deliver outcomes

👉 “Can this team actually execute?” is a key reviewer question

🏥 8. Strong Institutional Support

Backing from:
- NSW-based institutions (mandatory for most schemes)
Access to:
- Infrastructure
- Data
- Clinical settings

👉 NSW affiliation is a strict eligibility requirement

📊 9. Community & Consumer Involvement

Inclusion of:
- Patient perspectives
- Community engagement

👉 Increasingly important in evaluation

💰 10. Realistic Budget & Sustainability

Budget aligned with project scope
Long-term sustainability beyond funding

👉 Efficient use of public funds is emphasized

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

Alignment with NSW Cancer Plan
Real-world patient/population impact
Translational/implementation focus

Moderate predictors:
4. Collaboration with health system
5. Focus on underserved populations
6. Feasibility & study design

Supporting factors:
7. Investigator track record
8. Institutional support (NSW-based)
9. Budget & sustainability

💡 Insider Insight

Compared to other cancer funders:

Cancer Institute NSW is:
👉 health-system driven (policy + implementation focus)
Not purely academic or pharma-oriented

👉 Key success question:
“Will this improve cancer outcomes across NSW in a practical, scalable way?”

Specialties

Cancer

Eligibility Requirements

The 2026 Research Equipment Grant round is open to NSW-based Chief Investigators who have not received a Research Equipment Grant in the past three years, from a Registered Administering Institution.

Sponsor Details

Sponsor Institute/Organizations: Cancer Institute NSW

Sponsor Type: Corporate/Non-Profit

Address: Locked Bag 2030, St Leonards NSW 1590 Level 4, 1 Reserve Road St Leonards NSW 2065 ABN: 48 538 442 594

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity